FDA Identified Problems at Moderna Plant Making Substance for COVID Vaccine: Document

Moderna didn’t meet required rules, regulators found.

COVID-19 vaccines in a file photograph. Joseph Prezioso/AFP via Getty Images

U.S. Food and Drug Administration (FDA) inspectors uncovered problems at a Moderna plant used to manufacture a substance that is part of the company’s COVID-19 vaccine, according to a newly released document.

Moderna failed to meet multiple requirements, including rules aimed at minimizing the potential for contamination, according to the document.